[{"NetIncomeLoss_3_Q3_USD":-107724000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":11799000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":59754495.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":65958513.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q3_USD":78056000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":19475000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":344159000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":6000.0,"IncomeTaxesPaid_3_Q3_USD":482000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-92087000.0,"Depreciation_3_Q3_USD":1838000.0,"Depreciation_1_Q3_USD":649000.0,"DividendsCommonStockCash_3_Q3_USD":0.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3_Q3_USD":0.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":378413000.0,"CashCollateralForBorrowedSecurities_0_Q3_USD":210000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":10439647.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":331000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":14000.0,"Assets_0_Q3_USD":384413000.0,"ShareBasedCompensation_3_Q3_USD":14618000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1166000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":29821000.0,"OperatingLeaseLiability_0_Q3_USD":1547000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-3000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-27000.0,"ShortTermInvestments_0_Q3_USD":278521000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":455000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":74644000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":31419000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1593000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-969000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.8102,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q3_pure":0.8258,"IncomeTaxExpenseBenefit_3_Q3_USD":4363000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":667000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":226374000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":3000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":364395000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-107751000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-43839000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1704000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0056,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q3_pure":0.0036,"OtherAssetsNoncurrent_0_Q3_USD":48000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":85874000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":55000.0,"Liabilities_0_Q3_USD":25904000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":630000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":976000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":46000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":5768000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"RestrictedCashNoncurrent_0_Q3_USD":210000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":4163000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-27000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-3000.0,"OperatingLossCarryforwards_0_Q3_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-103361000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-43169000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5558000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-95341000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1124000.0,"LiabilitiesCurrent_0_Q3_USD":24892000.0,"LeaseCost_1_Q3_USD":371000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":38946000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":86084000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":14018000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":5681000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":774000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q3_pure":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0716,"AdditionalPaidInCapital_0_Q3_USD":822301000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":8000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":4573000.0,"NetIncomeLoss_1_Q3_USD":-43836000.0,"AccountsPayableCurrent_0_Q3_USD":3925000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1621000.0,"LeaseCost_3_Q3_USD":1154000.0,"VariableLeaseCost_1_Q3_USD":30000.0,"OperatingIncomeLoss_3_Q3_USD":-104465000.0,"OperatingIncomeLoss_1_Q3_USD":-43218000.0,"InvestmentIncomeInterest_3_Q3_USD":1104000.0,"InvestmentIncomeInterest_1_Q3_USD":49000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":4321000.0,"OperatingLeaseCost_3_Q3_USD":1022000.0,"OperatingLeaseCost_1_Q3_USD":341000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":384413000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":6747000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":14618000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":5558000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-463816000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":8736000.0,"OperatingExpenses_3_Q3_USD":104465000.0,"OperatingExpenses_1_Q3_USD":43218000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.8,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.66,"ProfitLoss_3_Q3_USD":-107724000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":957000.0,"StockholdersEquity_0_Q3_USD":358509000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":228000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":239000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3_Q3_USD":252300000.0,"VariableLeaseCost_3_Q3_USD":132000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1492000.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_Q3_USD":5463000.0,"Ticker":"KNSA","CIK":"1730430","name":"KINIKSA PHARMACEUTICALS, LTD.","OfficialName":"Kiniksa Pharmaceuticals Ltd. Class A Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"764985918.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]